<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[health care and pharmaceutical company Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/health+care+and+pharmaceutical+company.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to health care and pharmaceutical company]]></description>
	<s:counts start="0" returned="20" found="72" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Obama's Speech Offers Lucrative New Universe for Big Pharma]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10004212/obamas-speech-offers-lucrative-new-universe-for-big-pharma/]]></link>
		<description><![CDATA[President Obama's speech on Wednesday night laid down clear battle lines in the healthcare reform debate: drug companies are on Obama's side, health insurers and Republicans are on the other. It will be interesting to see who has the more powerful lobbyists, Big Pharma or Big Managed Care. by Jim...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 11 Sep 2009 08:26:49 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/barack+obama.html"><![CDATA[Barack Obama]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/obama.html"><![CDATA[Obama]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare+reform.html"><![CDATA[Healthcare Reform]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Pharma Lobbying Money: Who's Spending What Fighting Healthcare Reform]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10002798/pharma-lobbying-money-whos-spending-what-fighting-healthcare-reform/]]></link>
		<description><![CDATA[As President Obama waits for Congress to deliver a heathcare reform bill, pharmaceutical companies are spending millions on lobbyists to thwart any measure that might make drug prices cheaper or even allow the government to negotiate them, according to the Center for Responsive Politics.  Companies spent 41 percent more...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 22 Jun 2009 10:01:26 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare+reform.html"><![CDATA[Healthcare Reform]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Pharma Roundup: Johnson & Johnson, Abbott, Forest, and More]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000621/pharma-roundup-johnson-johnson-abbott-forest-and-more/]]></link>
		<description><![CDATA[An unhappy wind blows through Johnson & Johnson -- Patent expirations are taking their toll on the drug giant, which has seen profits slip and year-over-year sales drop 11 percent. Analysts predict an acquisition. [Source: Forbes, via Corey Nahman]    Abbott's diversification brings financial health -- The yin...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 21 Jan 2009 16:48:48 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/johnson+%2526+johnson.html"><![CDATA[Johnson & Johnson]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
		<category domain="tickers">JNJ</category>
	</item>
	<item>
		<title><![CDATA[Pharma Roundup: Daiichi's Ranbaxy Write-Down, Merck's UPS Deal, and More]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000562/pharma-roundup-daiichis-ranbaxy-write-down-mercks-ups-deal-and-more/]]></link>
		<description><![CDATA[Daiichi to lose $4 billion on Ranbaxy. UPS to run Merck distribution centers. Taro rejects Sun. U.S. prescription sales slump. by John Maas]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 06 Jan 2009 16:40:06 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/united+parcel+service+of+america+inc..html"><![CDATA[United Parcel Service Of America Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sun+microsystems+inc..html"><![CDATA[Sun Microsystems Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">JAVA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">UPS</category>
		<category domain="tickers">MRK,JAVA,UPS</category>
	</item>
	<item>
		<title><![CDATA[Starved of News, Press Speculates on Deals for Abbott, Pfizer and Wyeth]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000553/starved-of-news-press-speculates-on-deals-for-abbott-pfizer-and-wyeth/]]></link>
		<description><![CDATA[New Year is a slow news period, which is why the business press filled up with next-to-useless corporate strategy stories about Abbott Labs, Wyeth and Pfizer. The one thing these stories all have in common? They're long on speculation and short on substance. Let's take them one at a time....]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 05 Jan 2009 13:20:15 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/wyeth.html"><![CDATA[Wyeth]]></category>
		<category domain="http://resources.bnet.com/topic/abbott+laboratories+inc..html"><![CDATA[Abbott Laboratories Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/mahady.html"><![CDATA[Mahady]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">WYE</category>
		<category domain="tickers">ABT,PFE,WYE</category>
	</item>
	<item>
		<title><![CDATA[Drug Makers Gave Lobbyists an Xmas Gift -- Millions More to Lobby Obama Administration]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000547/drug-makers-gave-lobbyists-an-xmas-gift-millions-more-to-lobby-obama-administration/]]></link>
		<description><![CDATA[A New Year will bring a new president, a new FDA chief, many new drug regulations, and, possibly, health insurance reform. Mindful of the ton of major drug brands that will go off-patent in 2009, drug companies have not rested in their lobbying efforts over generics and patent issues. They...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 31 Dec 2008 11:36:49 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[Vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/administration.html"><![CDATA[Administration]]></category>
		<category domain="http://resources.bnet.com/topic/drug+company.html"><![CDATA[Drug Company]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+congress.html"><![CDATA[U.S. Congress]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/teva.html"><![CDATA[Teva]]></category>
		<category domain="http://resources.bnet.com/topic/biotech+drug.html"><![CDATA[Biotech Drug]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Pharma Roundup: Merck's Januvia, Bristol's Money, DTC Spending Down, and More]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000395/pharma-roundup-mercks-januvia-bristols-money-dtc-spending-down-and-more/]]></link>
		<description><![CDATA[DTC spending sinks; Merck carefully tests Januvia, not-so-carefully earns controversy by promoting Januvia to doctors; BMS will free a cool billion; Montel Williams to praise free market in PhRMA ads. by John Maas]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 14 Nov 2008 16:58:25 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://resources.bnet.com/topic/advertisement.html"><![CDATA[Advertisement]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">MRK</category>
	</item>
	<item>
		<title><![CDATA[Pharma Roundup: Obama May Decrease Drug Revenue, Strong Viagra and Cialis Sales, and More]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000330/pharma-roundup-obama-may-decrease-drug-revenue-strong-viagra-and-cialis-sales-and-more/]]></link>
		<description><![CDATA[Obama health plan provision could cost pharma billions in revenue; Viagra and Cialis sales still swelling; Glaxo opts for transparency; contract manufacturing worth $20 billion by John Maas]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 23 Oct 2008 17:16:58 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/revenue.html"><![CDATA[Revenue]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/viagra.html"><![CDATA[Viagra]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://resources.bnet.com/topic/revenue.html"><![CDATA[Revenue]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/viagra.html"><![CDATA[Viagra]]></category>
		<category domain="http://resources.bnet.com/topic/obama+health+plan.html"><![CDATA[Obama Health Plan]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
	</item>
	<item>
		<title><![CDATA[Seizing China's Pharma Opportunity]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=950905]]></link>
		<description><![CDATA[China's pharmaceutical market is growing by upward of 20 percent a year, but global drug companies still must capture its full potential. In less than a decade, China will be transformed from a secondary pharmaceutical market into the world's fifth largest. Companies aiming to capture a large chunk of it...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Fri, 01 Feb 2008 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
		<category domain="http://resources.bnet.com/topic/mckinsey+%2526+co..html"><![CDATA[McKinsey & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
	</item>
	<item>
		<title><![CDATA[Teva to Present at the Morgan Stanley Pharmaceutical CEO's Unplugged Conference and at the 26th Annual JPMorgan Healthcare Conference]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Jan_3/ai_n27487889]]></link>
		<description><![CDATA[JERUSALEM -- Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) will host a live audio webcast at the Morgan Stanley Pharmaceutical CEOs Unplugged Conference in NY and the 26th Annual JPMorgan Healthcare Conference in San-Francisco. Dan Suesskind, Chief Financial Officer and Bill Marth, President & CEO Teva Pharmaceuticals USA will present at Morgan...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 03 Jan 2008 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[health care]]></category>
		<category domain="http://resources.bnet.com/topic/morgan+stanley.html"><![CDATA[Morgan Stanley]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MS</category>
		<category domain="tickers">MS</category>
	</item>
	<item>
		<title><![CDATA[Pharmaceutical Jobs Offer Good Pay]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=375984]]></link>
		<description><![CDATA[Pharmaceutical jobs belong in the healthcare industry, a fast growing industry. An aging population and new developments in diagnosis and treatment leading to increased use of medication are the main factors leading this growth. The pharmaceutical industry itself is a big part of this growth story. In addition to bringing...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Tue, 01 Jan 2008 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/job.html"><![CDATA[Job]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
	</item>
	<item>
		<title><![CDATA[Stellar Pharmaceuticals Reports the Purchase of Stellar Shares in the Open Market by CEO and CFO]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200709/ai_n20516891]]></link>
		<description><![CDATA[Stellar Pharmaceuticals Inc., (TSX VENTURE: SLX) (OTCBB: SLXCF) ("Stellar" or the "Company"), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today reported that its CEO, Peter Riehl and CFO, Janice Clarke purchased a total of 20,000 shares of Stellar in the open...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 25 Sep 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[health care]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Patent Expiry of Blockbuster Drugs and Push for Lower Healthcare Costs Drive Generic Pharmaceuticals Market]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_August_15/ai_n27344178]]></link>
		<description><![CDATA[PALO ALTO, Calif. -- With several major blockbuster drugs reaching patent expiry, the market for generic pharmaceuticals in the United States is booming and is set to witness significant growth over the next few years. Demand for lower healthcare costs and pressure from payers to increase the use of generics...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 15 Aug 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/blockbuster+drug.html"><![CDATA[blockbuster drug]]></category>
		<category domain="http://resources.bnet.com/topic/blockbuster+inc..html"><![CDATA[Blockbuster Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[health care]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BBI</category>
		<category domain="tickers">BBI</category>
	</item>
	<item>
		<title><![CDATA[SCOLR Pharma Announces Receipt of Milestone Payment from Wyeth Consumer Healthcare]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Jan_30/ai_n27130554]]></link>
		<description><![CDATA[BELLEVUE, Wash. -- SCOLR Pharma, Inc. (Amex: DDD) announced today that it has received a second milestone payment under a previously disclosed License Agreement from Wyeth Consumer Healthcare, a division of Wyeth (NYSE: WYE). The cash payment under the SCOLR Pharma - Wyeth Consumer Healthcare agreement represents prepayment of a...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 30 Jan 2007 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[health care]]></category>
		<category domain="http://resources.bnet.com/topic/payment.html"><![CDATA[payment]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/wyeth.html"><![CDATA[Wyeth]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">WYE</category>
		<category domain="tickers">WYE</category>
	</item>
	<item>
		<title><![CDATA[In the interest of the patient: Convergence across the pharmaceutical and healthcare industries]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=332876]]></link>
		<description><![CDATA[While the pharmaceutical industry is seeking to replace the blockbuster model of drug development, healthcare is struggling with rapidly rising costs. This paper explores how, by collaborating and sharing data, the two industries can realize the full value of the information they collect--and improve patient treatments.   ]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Mon, 11 Dec 2006 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/convergence.html"><![CDATA[Convergence]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
	</item>
	<item>
		<title><![CDATA[Axcan Pharma to Participate in the Gastroenterology Panel at the 2006 RBC Capital Markets Healthcare Conference.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5559/is_200612/ai_n22538040]]></link>
		<description><![CDATA[MONT SAINT-HILAIRE, QUEBEC, Dec 8, 2006 CCNMatthews via COMTEX --  Axcan Pharma Inc. ("Axcan" or the "Company")  (TSX:AXP)(NASDAQ:AXCA) today announced that on Wednesday, December 13,  2006, President and Chief Executive Officer, F  MONT SAINT-HILAIRE, QUEBEC, Dec 8, 2006 CCNMatthews via COMTEX --  Axcan Pharma Inc....]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 08 Dec 2006 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[health care]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/rbc+capital+markets.html"><![CDATA[RBC Capital Markets]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Research and Markets: Wyeth Has planned Four New Launches In 2007 And Secured Entry into the Japanese Rheumatoid Arthritis Market]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_July_26/ai_n26937383]]></link>
		<description><![CDATA[DUBLIN, Ireland -- Wyeth is a global leader in pharmaceuticals, consumer healthcare and animal healthcare products. It has three primary businesses: Wyeth Pharmaceuticals Pharmaceuticals, Wyeth Consumer Healthcare Consumer Healthcare and Fort Dodge Animal Health Animal Health.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 26 Jul 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[health care]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/wyeth.html"><![CDATA[Wyeth]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">WYE</category>
		<category domain="tickers">WYE</category>
	</item>
	<item>
		<title><![CDATA[Othera Pharmaceuticals to Present at SG Cowen's 26th Annual Health Care Conference]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_Feb_21/ai_n16073126]]></link>
		<description><![CDATA[EXTON, Pa. -- Othera Pharmaceuticals, Inc., a specialty pharmaceuticals company focused on treating eye disease, today announced that its Chief Executive Officer David Joseph will be presenting at SG Cowen's 26th Annual Health Care Conference on Tuesday, March 7th, 2006 at 2:30 p.m. ET. The conference is being held at...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 21 Feb 2006 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[health care]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[U.S. Equity Strategy: The Health of Health Care]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=148477]]></link>
		<description><![CDATA[This article reports on the latest state of the healthcare market. Recent negative news in the drug sector has pushed down pharmaceutical stocks and provides an entry point given attractive valuations and dividends, as well as relative 2006 EPS growth prospects. Seasonal trading patterns also should benefit both pharmaceutical and...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Thu, 01 Sep 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/citigroup+inc..html"><![CDATA[Citigroup Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">C</category>
		<category domain="tickers">C</category>
	</item>
	<item>
		<title><![CDATA[Sanofi Aventis: because health matters.(Investor fact sheet)(Company Profile)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb3396/is_200509/ai_n18884152]]></link>
		<description><![CDATA[The largest pharmaceutical group in Europe and 3rd largest  pharmaceutical group in the world     The largest pharmaceutical group in Europe and 3rd largest  pharmaceutical group in the world   ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 01 Sep 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[health care]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/sanofi-aventis.html"><![CDATA[Sanofi-Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
</channel>
</rss>
